IMMU-32. RETARGETING IMMUNOEDITED GLIOMA ESCAPE VARIANTS WITH ADOPTIVE CELLULAR THERAPY

INTRODUCTION: Adoptive T cell immunotherapy (ACT) leads to extension of median survival and long-term cures of treatment-resistant models of malignant glioma, medulloblastoma, and pontine gliomas. While very promising, tailored strategies to overcome ACT failure are needed. Therefore, we studied the...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Wildes, Tyler, Dyson, Kyle, Grippin, Adam, DiVita, Bayli, Flores, Catherine, Mitchell, Duane
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216297/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.535
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items